Cramer: This 'cannabis' stock will quickly double

CNBC's Jim Cramer strongly endorsed an analyst's recommendation on a company that's developing medicines based on cannabis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.